Vaxtex Cotfab Valuation

VCL Stock   0.87  0.01  1.16%   
Today, the company appears to be overvalued. Vaxtex Cotfab Limited has a current Real Value of USD0.76 per share. The regular price of the company is USD0.87. Our model measures the value of Vaxtex Cotfab Limited from inspecting the company fundamentals such as Return On Equity of -0.42, price to book of 0.85 X, and Operating Margin of 3.81 % as well as reviewing its technical indicators and probability of bankruptcy.
Price Book
0.8508
Enterprise Value
260.7 M
Enterprise Value Ebitda
6.7687
Price Sales
2.5746
Enterprise Value Revenue
1.5687
Overvalued
Today
0.87
Please note that Vaxtex Cotfab's price fluctuation is dangerous at this time. Calculation of the real value of Vaxtex Cotfab Limited is based on 3 months time horizon. Increasing Vaxtex Cotfab's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Vaxtex stock is determined by what a typical buyer is willing to pay for full or partial control of Vaxtex Cotfab Limited. Since Vaxtex Cotfab is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Vaxtex Stock. However, Vaxtex Cotfab's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.87 Real  0.76 Hype  0.87 Naive  0.97
The real value of Vaxtex Stock, also known as its intrinsic value, is the underlying worth of Vaxtex Cotfab Limited Company, which is reflected in its stock price. It is based on Vaxtex Cotfab's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Vaxtex Cotfab's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
0.76
Real Value
3.73
Upside
Estimating the potential upside or downside of Vaxtex Cotfab Limited helps investors to forecast how Vaxtex stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Vaxtex Cotfab more accurately as focusing exclusively on Vaxtex Cotfab's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.790.921.06
Details
Hype
Prediction
LowEstimatedHigh
0.040.873.84
Details
Naive
Forecast
LowNext ValueHigh
0.020.973.94
Details

Vaxtex Cotfab Cash

191,520

Vaxtex Cotfab Total Value Analysis

Vaxtex Cotfab Limited is at this time forecasted to have takeover price of 260.72 M with market capitalization of 159.86 M, debt of 115.17 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Vaxtex Cotfab fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
260.72 M
159.86 M
115.17 M

Vaxtex Cotfab Investor Information

The company has Price to Book (P/B) ratio of 0.85. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Vaxtex Cotfab Limited recorded a loss per share of 0.62. The entity had not issued any dividends in recent years. The firm had 2:1 split on the 15th of February 2023. Based on the measurements of operating efficiency obtained from Vaxtex Cotfab's historical financial statements, Vaxtex Cotfab Limited is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February.

Vaxtex Cotfab Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Vaxtex Cotfab has an asset utilization ratio of 34.01 percent. This indicates that the Company is making USD0.34 for each dollar of assets. An increasing asset utilization means that Vaxtex Cotfab Limited is more efficient with each dollar of assets it utilizes for everyday operations.
 
Covid

Vaxtex Cotfab Profitability Analysis

The company reported the revenue of 166.2 M. Net Loss for the year was (88.34 M) with loss before overhead, payroll, taxes, and interest of (52.06 M).
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Vaxtex Cotfab's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Vaxtex Cotfab and how it compares across the competition.

About Vaxtex Cotfab Valuation

The stock valuation mechanism determines Vaxtex Cotfab's current worth on a weekly basis. Our valuation model uses a comparative analysis of Vaxtex Cotfab. We calculate exposure to Vaxtex Cotfab's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Vaxtex Cotfab's related companies.
Last ReportedProjected for Next Year
Gross Profit-47.2 M-44.8 M

Complementary Tools for Vaxtex Stock analysis

When running Vaxtex Cotfab's price analysis, check to measure Vaxtex Cotfab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxtex Cotfab is operating at the current time. Most of Vaxtex Cotfab's value examination focuses on studying past and present price action to predict the probability of Vaxtex Cotfab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxtex Cotfab's price. Additionally, you may evaluate how the addition of Vaxtex Cotfab to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Equity Valuation
Check real value of public entities based on technical and fundamental data